GlassScriptPhysician profile
James Andrew Smith
NPI 1508058900
$5,233.68
in general payments reported to CMS, 2019-2025
32 companies · $721 in 2025
The $721 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $562 · 2021: $1,152 · 2022: $647 · 2023: $738 · 2024: $884 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,098.80 | 2020-2024 | Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $692.96 | 2021-2025 | Venaseal, Kyphon Express II Kyphopak Tray, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $474.95 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $447.24 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $426.07 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $266.97 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $233.06 | 2019-2025 | Lokelma, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.69 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $134.59 | 2021-2023 | Verquvo |
| Amgen INC. | $125.00 | 2021-2025 | Repatha |
| Amarin Pharma, INC. | $123.23 | 2019-2022 | |
| Philips North America LLC | $122.77 | 2024-2025 | Igt Devices Undivided, (P84) Igt Devices Systems |
| Stryker Corporation | $116.84 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Veryan Medical Incorporated | $89.58 | 2022 | |
| Inari Medical, INC. | $82.67 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $72.32 | 2022-2025 | Ozempic |
| Pfizer INC. | $60.41 | 2022-2025 | |
| Cardiovascular Systems INC. | $53.50 | 2021-2022 | |
| Irhythm Technologies, INC. | $46.94 | 2019-2020 | |
| Atricure, INC. | $43.02 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Biotronik INC. | $38.23 | 2020 | |
| Biosense Webster, INC. | $37.81 | 2025 | Carto 3 |
| Bard Peripheral Vascular, INC. | $36.57 | 2025 | |
| Impulse Dynamics (USA) INC. | $28.64 | 2022 | |
| Chiesi USA, INC. | $26.00 | 2021-2022 | |
| Shockwave Medical, INC | $24.50 | 2022 | |
| Siemens Medical Solutions USA, INC. | $21.96 | 2022 | |
| Glaxosmithkline, LLC. | $21.82 | 2025 | Shingrix, Arexvy |
| Sanofi-Aventis U.S. LLC | $21.71 | 2019 | |
| Cvrx, INC. | $19.04 | 2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $18.69 | 2020 | |
| Davol INC. | $15.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.